Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 StudyNancy L. Bartlett, Marco Picardi, Árpád Illés et al.|Blood|2019Cited by 1